Skip to main content
. 2022 Mar 3;36(2):865–873. doi: 10.21873/invivo.12775

Table III. Results of a multivariate analysis for predicting discontinuation of Lenvatinib.

graphic file with name in_vivo-36-868-i0001.jpg

CI: Confidence interval; mALBI grade: modified albumin-bilirubin grade; GNRI: Geriatric Nutritional Risk Index. Significant p-Values are shown in bold.